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Strengths and limitations of this study
 ► Adverse childhood experiences (ACEs) are known to 
increase individuals’ risks of poor health across the 
life course, yet the financial burden they impose on 
national economies is largely unmeasured.
 ► We combined primary data on ACEs and 13 health 
outcomes from five general population ACE surveys 
undertaken in England and Wales.
 ► For each outcome, we generated population attrib-
utable fractions for cumulative ACE exposure and 
applied these to disability adjusted life years, which 
in turn allowed calculation of financial burden of 
ACEs using a modified human capital approach.
 ► ACE data were retrospectively reported and may 
be affected by recall bias, while general household 
surveys by their nature are likely to exclude those 
that have suffered the greatest impact of ACEs (eg, 
homelessness, incarceration or premature death).
 ► Although many major health outcomes were in-
cluded in the study, data are not yet available on all 
health outcomes potentially associated with ACEs 
and financial estimates are likely to be conservative.
AbStrACt
Objective To estimate the health and financial burden 
of adverse childhood experiences (ACEs) in England and 
Wales.
Design The study combined data from five randomly 
stratified cross- sectional ACE studies. Population 
attributable fractions (PAFs) were calculated for major 
health risks and causes of ill health and applied to 
disability adjusted life years (DALYs), with financial costs 
estimated using a modified human capital method.
Setting Households in England and Wales.
Participants 15 285 residents aged 18–69.
Outcome measures The outcome measures were PAFs 
for single (1 ACE) and multiple (2–3 and ≥4 ACEs) ACE 
exposure categories for four health risks (smoking, alcohol 
use, drug use, high body mass index) and nine causes of ill 
health (cancer, type 2 diabetes, heart disease, respiratory 
disease, stroke, violence, anxiety, depression, other mental 
illness); and annual estimated DALYs and financial costs 
attributable to ACEs.
results Cumulative relationships were found between 
ACEs and risks of all outcomes. For health risks, PAFs for 
ACEs were highest for drug use (Wales 58.8%, England 
52.6%), although ACE- attributable smoking had the highest 
estimated costs (England and Wales, £7.8 billion). For causes 
of ill health, PAFs for ACEs were highest for violence (Wales 
48.9%, England 43.4%) and mental illness (ranging from 
29.1% for anxiety in England to 49.7% for other mental 
illness in Wales). The greatest ACE- attributable costs were for 
mental illness (anxiety, depression and other mental illness; 
England and Wales, £11.2 billion) and cancer (£7.9 billion). 
Across all outcomes, the total annual ACE- attributable cost 
was estimated at £42.8 billion. The majority of costs related 
to exposures to multiple rather than a single ACE (ranging 
from 71.9% for high body mass index to 98.3% for cancer).
Conclusions ACEs impose a substantial societal burden 
in England and Wales. Policies and practices that prevent 
ACEs, build resilience and develop trauma- informed 
services are needed to reduce burden of disease and 
avoidable service use and financial costs across health 
and other sectors.
IntrODuCtIOn
Evidence linking adverse childhood experi-
ences (ACEs) to the adoption of health risk 
behaviours and the development of mental 
and physical illness has burgeoned in recent 
years.1 The term ACEs is used to describe 
some of the most intense sources of stress 
that children can suffer while growing 
up, such as being maltreated, witnessing 
domestic violence or coping with parental 
substance abuse.2 Such experiences can 
have harmful effects on children’s devel-
oping neurological and physiological 
systems that can embed vulnerability to poor 
health and well- being. Thus repeated acti-
vation of the stress response system during 
childhood and a lack of responsive interac-
tion with caring adults can impact on brain 
structure, neuroendocrine stress regulation, 
immune functioning and metabolic health, 
as well as social and emotional develop-
ment.3 4 Consistent with such effects, ACEs 
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have been associated with delayed child development 
(eg, cognitive and language skills), childhood health 
and behavioural conditions, the adoption of health 
risk behaviours (eg, substance use), mental illness (eg, 
depression), and early development of chronic health 
conditions (eg, cancer).1 5–8
Numerous studies have explored the health impacts 
and costs of specific ACEs such as child maltreatment.9–11 
However, the ACE framework provides a mechanism for 
measuring a range of ACE types and the cumulative risks 
they impose at a population level.2 Studies using this 
approach show a dose–response relationship between 
the number of ACEs suffered and poor outcomes across 
multiple domains, including health, criminal justice, 
education and employment.12–15 Studies also show that 
most individuals who report having suffered any specific 
ACE type (eg, physical abuse) also report other ACE 
types.16 Consequently, prevention efforts focused on any 
individual ACE type are likely to have limited success if 
the range of other ACEs affecting families are left unad-
dressed. The rapid proliferation of awareness on the 
impacts of ACEs on the policy priorities of different sectors 
is driving multiagency action to enhance early interven-
tion and develop trauma- informed services.17 18 However, 
such policy development requires an understanding of 
the financial costs of ACEs to society and consequently 
the potential gains to be made by preventing ACEs for 
future generations.
Estimates of the financial burden of ACEs are only 
just starting to emerge. A recent study estimated that 
the annual costs attributable to ACEs for four risk 
factors (smoking, alcohol use, drug use and obesity) 
and six causes of ill health (anxiety, depression, cancer, 
diabetes, cardiovascular disease and stroke) reached 
$581 billion in Europe and $748 billion in North 
America, equivalent to around 3% of each region’s gross 
domestic product (GDP).12 Here, we combine primary 
data from five ACE studies undertaken in England 
and Wales to develop national population attributable 
fractions (PAFs) for ACEs across an extended range of 
outcomes. We use these data to estimate the annual cost 
of the health burden resulting from the lifelong impact 
of ACEs on residents of England and Wales using a 
modified human capital model.
MethODS
Primary data sources
We combined data from five cross- sectional ACE studies 
conducted across various geographies in England and 
Wales between 2012 and 2017.19–23 Summary informa-
tion on each study is provided in online supplementary 
table S1. All studies used stratified random sampling 
approaches with lower super output area (LSOA; small 
geographical areas with a mean population of 1500) as 
the sampling unit. LSOAs were categorised into depriva-
tion quintiles based on their ranking in the English24 or 
Welsh25 Indexes of Multiple Deprivation, both of which 
are composite measures including a range of economic 
and social indicators. Sample selection was stratified by 
region (as appropriate; see online supplementary table 
S1) then deprivation quintile based on the population 
profile of the relevant study area. Households in sampled 
areas were identified using the national postcode address 
file. In four studies, randomly selected households were 
sent a letter prior to researcher visits that provided infor-
mation on the study and the opportunity to opt out. In 
one study,22 researchers randomly selected households 
in sampled LSOAs and provided study information mate-
rials at the door. Interviews were undertaken face to face 
at participants’ homes by professional market research 
companies using computer- assisted personal interviewing. 
Informed consent was obtained from all participants. 
Sensitive questions, including those on ACEs, were self- 
completed. Participation was voluntary and anonymous 
and only one resident participated per selected house-
hold (inclusion criteria: within age range, resident in 
the LSOA, cognitively able to participate in a face- to- face 
interview). Across the five samples, the weighted average 
compliance was 55.7% (see online supplementary table 
S1), with a total sample size of 15 658. For this study, data 
were restricted to individuals aged 18–69 with complete 
demographic and ACE data, resulting in a final sample 
of 15 285.
All questionnaires used the Centers for Disease Control 
and Prevention short ACE tool26 to collect data on nine 
ACEs occurring before the age of 18: physical abuse, 
sexual abuse, verbal abuse, parental separation, exposure 
to domestic violence, and household member alcohol 
abuse, drug abuse, mental illness and incarceration. 
For the purpose of analysis, and in line with previous 
studies,1 19–23 positive responses to ACE questions were 
summed and participants were allocated to an ACE count 
category: 0 ACE, 1 ACE, 2–3 ACEs and ≥4 ACEs. Ques-
tions used to determine ACEs and the 13 health outcomes 
analysed in this study are shown in online supplementary 
table S2. All studies provided data on smoking (current 
smoker), drug use (ever used heroin or crack cocaine) 
and violence (victimisation in the past year). Four studies 
provided data on alcohol use (current, ≥12 g per day), 
high body mass index (BMI, ≥25.0 kg/m2), and whether 
respondents had ever been diagnosed with cancer, type 
2 diabetes, heart disease (coronary heart disease/heart 
attack), stroke or respiratory disease. One study provided 
data on whether respondents had ever been treated 
for depression, anxiety and other mental illness (see 
online supplementary table S3). Demographic variables 
included gender, age, ethnicity (self- assigned using UK 
census categories) and deprivation quintile.
Calculating PAFs
Statistical analysis was undertaken in SPSS V.23, with 
data editing and calculations undertaken in Excel. 
Binomial generalised linear modelling was used to 
calculate risk ratios (RRs) and 95% CIs associated with 
ACE count level for each health outcome, controlling 
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Table 1 Risk ratios for risk factors and causes of ill health at each ACE count level
1 ACE 2–3 ACEs ≥4 ACEs
RR 95% CI P value RR 95% CI P value RR 95% CI P value
Risk factors
  Alcohol use 1.164 1.041 to 1.301 0.008 1.311 1.165 to 1.475 <0.001 1.837 1.631 to 2.069 <0.001
  Smoking 1.188 1.091 to 1.293 <0.001 1.448 1.329 to 1.578 <0.001 2.079 1.904 to 2.270 <0.001
  Drug use 1.648 1.168 to 2.327 0.005 3.184 2.342 to 4.330 <0.001 8.685 6.658 to 11.328 <0.001
  High BMI 1.031 0.986 to 1.078 0.177 1.062 1.012 to 1.115 0.015 1.075 1.011 to 1.142 0.020
Causes of ill health
  Depression 1.560 1.305 to 1.865 <0.001 2.137 1.820 to 2.509 <0.001 2.766 2.374 to 3.223 <0.001
  Anxiety 1.429 1.169 to 1.747 <0.001 2.151 1.806 to 2.563 <0.001 2.751 2.316 to 3.266 <0.001
  Other mental illness 1.684 1.008 to 2.812 0.046 3.216 2.083 to 4.964 <0.001 5.115 3.356 to 7.796 <0.001
  Violence 1.383 1.107 to 1.728 0.004 2.955 2.448 to 3.566 <0.001 5.625 4.745 to 6.667 <0.001
  Cancer 1.009 0.800 to 1.273 0.937 1.101 0.854 to 1.419 0.459 2.078 1.588 to 2.720 <0.001
  Type 2 diabetes 1.157 0.958 to 1.398 0.131 1.223 0.995 to 1.503 0.056 1.782 1.400 to 2.268 <0.001
  Heart disease 1.102 0.836 to 1.453 0.492 1.415 1.072 to 1.868 0.014 1.928 1.366 to 2.722 <0.001
  Stroke 1.238 0.800 to 1.918 0.338 1.427 0.906 to 2.250 0.125 2.705 1.660 to 4.409 <0.001
  Respiratory disease 1.224 0.927 to 1.615 0.155 1.806 1.383 to 2.358 <0.001 2.612 1.929 to 3.536 <0.001
Analysis used generalised linear modelling controlling for study sampling region, deprivation quintile, age, gender and ethnicity.
Reference category: 0 ACE.
ACE, adverse childhood experience; BMI, body mass index; CI, confidence interval; RR, risk ratio.
for study sampling region, deprivation quintile of resi-
dence, gender, age and ethnicity (white or non- white). 
In line with cost estimates for global regions,12 we calcu-
lated PAF values at each ACE count level (1 ACE vs 0 





where α is the category of ACE count for the PAF in ques-
tion, RRACE is the pooled RR associated with each ACE 
count, and PACE is the proportion of the sample exposed to 
each ACE count. Overall PAFs for ACEs were generated by 
summing the three PAF values.27 Separate PAFs were gener-
ated for England and Wales using regional ACE prevalence 
levels.
Calculating ACe-attributable costs
Consistent with previous studies,11 12 28 we used a modified 
human capital approach to calculate ACE- attributable 
costs associated with each health outcome. The human 
capital approach is a commonly used method in economic 
evaluations to calculate the cost of lost productivity to 
society as a result of separation of an individual from 
the labour force due to premature death or morbidity.29 
Health outcomes were matched to risk factor and cause 
categories in the 2017 Global Burden of Disease Study30 
(GBD; see online supplementary table S4). For each 
matched category, disability adjusted life years (DALY) 
estimates were extracted for England and Wales for 
age categories 15–49 years, 50–69 years and 70+ years. 
Previous cost estimates using a human capital approach 
have assumed one DALY is equal to a region’s GDP 
per capita and calculated costs based on DALYs × GDP 
per capita.11 12 28 GDP was not calculated separately for 
England and Wales; thus, we used the related measure of 
regional gross value added (GVA; equivalent to GDP plus 
subsidies less taxes on products), with GVA per capita 
(balanced, current basic 2017 prices) being £28 096 for 
England and £19 899 for Wales.31 PAFs were applied to the 
total cost (by UK region) for each risk factor and cause to 
estimate the economic value of DALYs by ACE level. The 
equivalent value of DALYs as a proportion of total GVA 
was also calculated. To estimate the total costs attributed 
to ACEs across all health outcomes studied, we excluded 
DALYs for risk factors that related to included causes of 
ill health (eg, those for alcohol use attributed to cancer). 
Sensitivity analyses were run limiting DALYs to individuals 
aged 15–69 years old, using the upper and lower bounds 
(uncertainty intervals) for DALYs (extracted from the 
GBD) and by generating PAFs using the upper and lower 
CIs for RRs.
Patient and public involvement
Patients and the public were not involved in the design or 
planning of the study.
reSultS
Demographics and ACE count levels of the individual 
and combined study samples are shown in online supple-
mentary table S5. Across the combined samples, over half 
(54.9%) of participants were female and 85.7% were of 
white ethnicity. ACE prevalence levels (used to generate 
PAFs) were 53.1% for 0 ACE, 19.0% for 1 ACE, 15.2% for 
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2–3 ACEs and 12.6% for ≥4 ACEs in Welsh samples, and 
56.2% for 0 ACE, 20.1% for 1 ACE, 15.4% for 2–3 ACEs 
and 8.4% for ≥4 ACEs in English samples.
RRs for each ACE count level and each health outcome 
are presented in table 1 (unadjusted proportions are 
provided in online supplementary table S6). All outcomes 
showed a graded relationship with ACEs, with RRs 
increasing as ACE count increased. Risks of alcohol use, 
smoking, drug use, violence and mental illness outcomes 
were increased in individuals with any level of ACEs. Risks 
of high BMI, heart disease and respiratory disease were 
increased in individuals with ≥2 ACEs, and risks of type 
2 diabetes, cancer and stroke in those with ≥4 ACEs only.
The total PAFs for ACEs were slightly higher in Wales 
than in England for all outcomes due to higher ACE 
prevalence levels (table 2). Across the four risk factors, 
drug use had the highest PAFs due to ACEs (58.8% Wales, 
52.6% England). However, smoking carried the highest 
ACE- attributable costs given the higher number of DALYs 
for this risk factor. ACE- attributable costs due to smoking 
were £7.4 billion in England and £466.5 million in Wales. 
High BMI had the lowest PAFs due to ACEs (2.4% Wales, 
2.2% England), although ACE- attributable costs still 
reached £729.2 million in England and £35.3 million in 
Wales. Across causes of ill health, violence and mental 
illness had the highest PAFs due to ACEs, while cancer 
and type 2 diabetes had the lowest. ACEs were attributed 
to 48.9% of recent violence victimisation in Wales and 
43.4% in England, with associated costs of £16.6 million 
and £355.0 million, respectively. Up to a third of depres-
sion and anxiety and almost half of other mental illnesses 
were attributed to ACEs, with associated costs across 
the three mental health outcomes being £465.3 million 
in Wales and £10.7 billion in England. Despite having 
low PAFs, high DALYs for cancer meant that this cause 
carried the greatest ACE- attributable costs across all indi-
vidual outcomes measured, reaching £476.4 million in 
Wales and £7.5 billion in England.
Across all nine causes of ill health, the total ACE- 
attributable cost was £33.9 billion (£1.7 billion for Wales 
and £32.1 billion for England). To calculate the total 
ACE- attributable cost across all risk factors and causes of 
ill health, we excluded DALYs from the four risk factors 
that related to included causes (eg, those for smoking 
related to cancer). The total ACE- attributable cost was 
£42.8 billion (£2.2 billion for Wales and £40.6 billion for 
England; table 3). These costs are equivalent to 3.5% of 
the total annual GVA in Wales and 2.6% in England (2.6% 
across the combined geographies). In sensitivity analysis 
(see the Methods section), combined estimated ACE- 
attributable costs for England and Wales ranged from 
£16.3 billion (equivalent to 1.0% of GVA) to £68.4 billion 
(4.2% of GVA; table 3).
Figure 1 shows the proportion of ACE- attributable costs 
for each outcome that were accounted for by 1, 2–3 and 
≥4 ACEs. For cancer, the 1 ACE category accounted for 
only 1.7% of ACE- attributable financial costs, while the ≥4 
ACEs category accounted for 84.2%. For other outcomes, 
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the proportion of costs accounted for by the 1 ACE cate-
gory ranged from 9.9% (violence) to 28.1% (high BMI), 
while the proportion accounted for by ≥4 ACEs ranged 
from 28.9% (high BMI) to 58.6% (drug use).
DISCuSSIOn
In this study of 15 285 adults in England and Wales, we 
found a dose–response relationship between ACEs and 
all outcomes measured. Violence, mental illness and drug 
use had the highest PAFs due to ACEs, while mental illness, 
cancer and smoking carried the highest ACE- attributable 
costs. Across all outcomes studied, the total estimated 
annual ACE- attributable cost across England and Wales 
was £42.8 billion, equivalent to 2.6% of the total GVA 
in England and Wales and representing approximately 
£1800 per household per annum.32 The majority of these 
costs related to multiple ACE categories.
Comparison with other studies
There are no previous studies estimating the costs of ACEs 
in England and Wales. However, a study that generated 
PAFs for ACEs through meta- analyses of risk estimates in 
published literature estimated the annual costs of ACEs 
to be equivalent to 2.7% of GDP in Europe and 3.6% of 
GDP in North America.12 Other studies have measured 
the costs of specific ACEs, particularly violence against 
children, using similar human capital approaches. Such 
costs have been estimated to be equivalent to between 
1.2% and 3.5% of subregional GDP in East Asia and the 
Pacific11; to 4.3% of GDP in South Africa33; and to 0.8% 
of GDP for physical abuse, 0.5% for emotional abuse 
and 0.4% for sexual abuse in China.34 In the UK, the 
lifetime cost per victim of non- fatal child maltreatment 
by a primary caregiver has conservatively been estimated 
at £90 000.35 However, this estimate excluded costs for 
several outcomes considered in our study, including 
those for cancer, type 2 diabetes and heart disease, due 
to no association being found between these conditions 
and the study’s single measure of child maltreatment. We 
found no associations between such conditions and the 
single ACE category, yet strong associations with multiple 
ACEs. Thus 98.3% of the ACE- attributable costs of cancer, 
87.6% of those for heart disease and 76.3% of those for 
type 2 diabetes were accounted for by suffering more 
than one type of ACE.
Strengths and weaknesses of the study
We used an established methodology11 12 28 and based our 
approach on that used to estimate the financial burden 
of ACEs across Europe and North America.12 An acknowl-
edged limitation of this previous study was the lack of 
consistency in study methodologies. Key strengths of the 
current study are the use of primary data and consistency 
in study methodologies, with all studies using representa-
tive household samples and the same set of questions to 
measure ACEs. However not all outcomes were measured 
in all studies, and mental illness was only measured in 
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Figure 1 Proportion of ACE- attributable costs for each risk factor and cause of ill health attributed to 1, 2–3 and ≥4 ACE 
categories. ACE, adverse childhood experience; BMI, body mass index.
Wales,23 while some outcome measures could not be 
matched directly to GBD categories (see online supple-
mentary table S4). Like previous ACE studies, the retro-
spective, self- reported nature of questions makes findings 
subject to recall issues and any reluctance to report histor-
ical experiences. Further, some population groups who 
may be at increased exposure to ACEs (eg, those incarcer-
ated36 or homeless37) will have been under- represented 
and we could not account for individuals that had died 
prematurely through conditions related to ACEs. These 
biases may have led to reduced relative risks. Conversely, 
while ACEs made an overall significant contribution to 
GLMs (generalised linear models) for all outcomes, for 
some, RRs were not significant at all ACE levels. Further, 
our samples were restricted to adults aged 18–69 years, 
yet some conditions such as stroke occur predominantly 
in older age groups. Consequently sensitivity analyses 
were undertaken limiting DALYs to the 15–69 years age 
group and using lower and upper CIs for RRs. While we 
excluded DALYs for risk factors linked to included causes 
of ill health in calculating our overall cost estimates, it 
is beyond the ability of this study to calculate the actual 
burden of ACEs due to multiplicative relationships. 
However, our estimates of the costs of ACEs are likely to 
be conservative. While we included many key risks for, 
and causes of, ill health associated with ACEs, we did not 
account for other associated outcomes (eg, risky sexual 
behaviour, suicide, crime), nor for the burden of child 
deaths related to ACEs. A study of child death reviews in 
an English locality found evidence of at least one ACE 
in the records of 63% of children that died over a 4- year 
period and of at least four ACEs in 20% of cases.38 The 
lifetime cost of a child maltreatment death in the UK has 
been estimated at almost £1 million.35
Meaning of the study
Nearly half of all adults in England and Wales experi-
enced some form of ACE as a child and around one in 
ten experienced ≥4 ACEs (see online supplementary 
table S5). This equates to approximately 20 million adults 
with any ACE and four million with ≥4 ACEs. Our results 
quantify the substantive proportion of common health- 
harming behaviours and long- term health conditions 
that are associated with ACEs, and consequently that 
could be avoided in future generations through offering 
better quality childhoods. Currently, however, an esti-
mated 2.3 million children in England live in families 
with substantial complex needs and only a third of these 
children are receiving established support from statu-
tory services.39 An imperative to increase expenditure on 
safe and nurturing childhoods is emphasised by findings 
that around a third of mental illness could be avoided 
if ACEs were either prevented or their impacts moder-
ated through early intervention. Mental illness carries 
one of the highest costs to health systems in England and 
Wales40 and also creates substantial pressure on educa-
tional, social and criminal justice systems. For the latter in 
particular, strong relationships found here between ACEs 
and violence are an additional concern with many types 
of police- recorded violence increasing in England and 
Wales.41 Across all measured outcomes, we identify poten-
tially avoidable costs from ACEs equivalent to more than a 
quarter of the UK’s annual government healthcare expen-
diture.42 The potential to avoid such costs is unrealised 
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while the majority of health expenditure focuses on 
adults who have already developed pathologies. Evidence- 
based mechanisms to prevent ACEs and build resilience 
to their long- term harms are available, offering return on 
investments in years rather than decades through bene-
fits on child development, health and education.43–46 The 
benefits of such interventions reach across sectors, and a 
whole of government approach could more immediately 
resource interventions capable of diminishing a current 
annual ACE burden of almost £43 billion.
unanswered questions and future research
As with most ACE studies our data were collected retro-
spectively and consequently provide no information on 
the current levels of ACEs experienced by children in 
England and Wales. Options to measure ACE prevalence 
now form part of the international Health Behaviour in 
School- aged Children Survey47 but have not yet been used 
in the English or Welsh survey iterations, nor are such data 
routinely being collected through other major school- 
based surveys in the UK. While estimates of current expo-
sure to some ACEs are available,39 routine measurement 
of ACEs in children is required to better understand their 
extent and sociodemographic and geographical distri-
bution, as well as the impact of interventions to address 
them. Further, our findings identified that, despite having 
the lowest prevalence, the majority of costs generated 
by ACEs fall on those experiencing ≥4 ACEs (table 2). 
There is an urgent need to better understand the cumu-
lative impact of ACEs on health outcomes across the life 
course, integrating epidemiology with fields including 
epigenetics, immunology and neurology. Equally, there is 
a critical need for knowledge on how services can become 
more trauma- informed, what impact trauma- informed 
service delivery can have, and how services for children 
and families affected by child maltreatment, substance 
abuse, domestic violence or incarceration, for instance, 
can be better integrated to provide a cohesive offer. 
Finally, as well as the core ACE categories included here, 
measurements of other childhood adversities such as 
neglect, parental bereavement, bullying and exposure to 
community level violence are increasingly being incorpo-
rated into the list of potential ACEs. Public services that 
recognise the impact of childhood adversity on lifelong 
health but neglect to implement preventative measures 
may yet feature in future lists.
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